- Hypersensitivity to empagliflozin or linagliptin - Severe kidney impairment (eGFR <30 mL/min/1.73 m²) - End-stage renal disease (ESRD) - Dialysis - Pregnancy and lactation (caution advised)
Precautions
- Monitor blood sugar, kidney function, and liver enzymes regularly - Inform doctor about concomitant medications - Caution in patients with: - Renal or hepatic impairment - History of pancreatitis - History of hypersensitivity reactions
Find products similar to Empagliflozin 25 Mg & Linagliptin 5 Mg Tablets - Glimpazin-L 25 (100 Tablets)
Merdica Private Limited was established in 2019 with a vision to provide high-quality and affordable pharmaceutical solutions across a wide spectrum of healthcare needs. As a trusted Wholesale Trader, we specialize in offering a comprehensive range of tablets that cater to various therapeutic areas, including Anti-Diabetic, Cardiology, Urology, Nephrology, Multivitamins & Food Supplements, Thyroid, GIT Acting Drugs, Anticoagulants, Neuropsychiatric Medicines, Rheumatoid Arthritis, and Antibiotics.
Under the leadership of CEO Neeraj Sharma, Merdica Private Limited has steadily grown into a reliable name in the pharmaceutical industry. Our company is committed to ensuring the highest quality standards, strict compliance with regulatory requirements, and a focus on timely delivery to our clients.
We pride ourselves on building long-term relationships with healthcare professionals, suppliers, and clients, ensuring that we provide only the best products for improving patient health and well-being.
